Mary Beth Berkes
Principal, the Shorewood Group
Mary Beth Berkes is an investor in healthcare companies. She is Principle at Shorewood Group LLC. She is Co-Founding Partner of Linden Capital Partners, a middle market healthcare private equity firm headquartered in Chicago, IL. Ms. Berkes has been involved in healthcare for over 30 years with a focus on medical devices, healthcare services, and the pharmaceutical industry. She has significant governance experience on boards of directors of healthcare companies and organizations and Chair of Audit, Compensation and Organizational Development Committees. She also served on the Limited Partner and Investment Committees at Linden. Prior to founding Linden, she spent 18 years as a senior executive at Bristol-Myers Squibb in the ConvaTec division, a $1.2 billion medical device company. She has held senior positions domestically and internationally in general management, marketing, sales, mergers and acquisitions, and operations. At ConvaTec, Ms. Berkes led turnarounds of many operations globally and held senior positions where she successfully drove strategic re-alignment and operational transformations. Previously, she worked in cancer and antibiotic research at the Medical College of Wisconsin. Currently, Ms. Berkes serves on the Board of Directors of SteadMed Inc., the Advisory Board of Somna Therapeutics, and she serves on the boards of: Froedtert Health, The Greater Milwaukee Foundation, The United Community Center, and Alverno College.. Ms. Berkes received a B.S.N. from Alverno College and an M.B.A. from the Kellogg Graduate School of Business at Northwestern University. She is a member of The Chicago Network and lives in Shorewood, WI.